Antineutrophil cytoplasmic antibodies as markers for systemic autoimmune disease

Clinics in Chest Medicine

Volumn 19, Issue 4, 1998, Pages 627-639

  Homer, R J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032411916     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70107-6     Document Type: Article

References (106)

1. S. Akimo O. Ishikawa T. Tamura Antineutrophil cytoplasmic antibodies in patients with systemic sclerosis Br J Dermatol 134 1996 407
2. R.J. Alpern Vasculitis: It's time to reclassify Am J Med Sci 309 1995 235
3. L.G. Ardiles G. Valderrama P. Moya Incidence and studies on antigenic specificities of antineutrophil cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis Clin Nephrol 47 1997 1
4. B. Baslund M. Segelmark A. Wiik Screening for antineutrophil cytoplasmic antibodies (ANCA): Is indirect immunofluorescence the method of choice? Clin Exp Immunol 99 1995 486
5. M. Blank Y. Tomer M. Stein Immunization with antineutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocytic infiltration Clin Exp Immunol 102 1995 120
6. X. Bosch R. Asherson The antigenic significance and methods of detection of the antineutrophil cytoplasmic autoantibodies Postgrad Med J 68 1992 707
7. X. Bosch A. Lopez-Soto E. Mirapeix Antineutrophil cytoplasmic autoantibody associated alveolar capillaritis in patients presenting with pulmonary hemorrhage Arch Pathol Lab Med 118 1994 517
8. X. Bosch E. Mirapeix J. Font Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in antiglomerular basement membrane disease Clin Nephrol 36 1991 107
9. X. Bosch A. Urbano-Marquez Letter to the editor Lancet 347 1996 117
10. I.N. Bruce A.L. Bell A comparison of two nomenclature systems for primary systemic vasculitis Br J Rheumatol 36 1997 453
11. F. Callea G. Gregorini A. Sinico alpha 1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: Genetic and clinical implications Eur J Clin Invest 27 1997 696
12. G. Cambridge M. Williams B. Leaker Antimyeloperoxidase antibodies in patients with rheumatoid arthritis: Prevalence, clinical correlates and IgG subclass Ann Rheum Dis 53 1994 24
13. L. Chang S. Binos J. Savige Epitope mapping of antiproteinase 3 and antimyeloperoxidase antibodies Clin Exp Immunol 102 1995 112
14. L. Charles M. Caldas R. Falk Antibodies against granule proteins activate neutrophils in vitro J Leukoc Biol 50 1991 539
15. M. Chiba U. Specks The presence of c-ANCA determines the clinical course of Wegener's granulomatosis limited to the respiratory tract Sarcoidosis Vasc Diffuse Lung Dis 13 1996 266
16. J. Cohen Tervaert R. Goldschmelding J. Elema Autoantibodies against myeloid lysozomal enzymes in crescentic glomerulonephritis Kidney Int 37 1990 799
17. J. Cohen Tervaert R. Goldshmelding J. Elema Association of autoantibodies to myeloperoxidase with different forms of vasculitis Arthritis Rheum 33 1990 1264
18. J.W. Cohen Tervaert C.A. Stegeman C.G. Kallenberg Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides Sarcoidosis Vasc Diffuse Lung Dis 13 1996 241
19. T.V. Colby ANCA defines the clinical disease manifestations of vasculitis. The “con” side of the issue Sarcoidosis Vasc Diffuse Lung Dis 13 1996 227
20. J.F. Cordier A lung biopsy is unnecessary in the management of ANCA-positive patients with chest-roentgenographic abnormalities Sarcoidosis Vasc Diffuse Lung Dis 13 1996 235
21. E. Csernok M. Ernst W. Schmitt Activated neutrophils express proteinase 3 on their plasma membranes in vitro and in vivo Clin Exp Immunol 95 1994 244
22. A. Davenport R. Lock T. Wallington Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms Thorax 49 1994 213
23. A. Davenport R. Lock T. Wallington Clinical significance of antineutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay Q J Med 87 1994 291
24. M. de Bandt O. Meyer T. Haim Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients Br J Rheumatol 35 1996 38
25. M. de Bandt O. Meyer J. Hakim Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1 (ICAM-1, CD 54) Br J Rheumatol 36 1997 839
26. M. de Bandt V. Ollivier O. Meyer Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells Arthritis Rheum 40 1997 2030
27. R. DeRemee H. Homburger U. Specks Lesions of the respiratory tract associated with the finding of antineutrophil cytoplasmic autoantibodies with a perinuclear staining pattern Mayo Clin Proc 69 1994 819
28. J. Edgar S. McMillan I. Bruce An audit of ANCA in routine clinical practice Postgrad Med J 71 1995 605
29. V. Esnault A. Short M. Audrain Autoantibodies to lactoferrrin and histone in systemic vasculitis identified by antimyeloperoxidase solid phase assays Kidney Int 46 1994 153
30. R. Falk S. Hogan T. Carey Clinical course of antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis Ann Intern Med 113 1990 656
31. R. Falk J. Jennette Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 1988 1651
32. R. Falk R. Terrel L. Charles Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro Proc Natl Acad Sci U S A 87 1990 4115
33. R.J. Falk D.T. Moore S.L. Hogan A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis Sarcoidosis Vasc Diffuse Lung Dis 13 1996 230
34. A. Fauci B. Haynes P. Katz Wegener's granulomatosis: Prospective and therapeutic experience with 85 patients over 21 years Ann Intern Med 98 1983 76
35. R. Fienberg E. Mark M. Goodman Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis Hum Pathol 24 1993 160
36. C. Franssen J. Cohen Tervaert C. Stegman Letter to the editor Lancet 347 1996 116
37. A. Gal F. Salina G.J. Staton The clinical and pathological spectrum of antineutrophil cytoplasmic autoantibody related pulmonary disease Arch Pathol Lab Med 118 1994 1209
38. C. Galperin Y. Shoenfeld B. Gilburd Antineutrophil cytoplasmic antibodies in patients with chromomycosis Clin Exp Rheumatol 14 1996 479
39. P. Gaudin F. Askin R. Falk The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and antimyeloperoxidase Am J Clin Pathol 104 1995 7
40. G. Godman J. Churg Wegener's granulomatosis. Pathology and review of the literature Arch Pathol 58 1954 533
41. J. Goeken Antineutrophil cytoplasmic antibody-A useful serologic marker for vasculitis J Clin Immunol 11 1991 161
42. E. Hagen K. Andrassy E. Chernok The value of indirect immunofluorescence and solid phase techniques for ANCA detection J Immunol Methods 159 1993 1
43. E. Hagen B. Ballieux L. van Es Antineutrophil cytoplasmic autoantibodies: A review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences Blood 81 1993 1996
44. E. Hagen M. Daha J. Hermans Diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis Kidney Int 53 1998 743
45. E.C. Hagen van dV-RH de KRJ Uveitis and antineutrophil cytoplasmic antibodies Clin Exp Immunol 95 1994 56
46. C. Halma M. Daha E. Schrama Value of antineutrophil cytoplasmic autoantibodies and other laboratory parameters in follow up of vasculitis Scand J Rheumatol 19 1990 392
47. D.R. Hull S.A. McMillan I.M. Rea Antineutrophil cytoplasmic antibodies in myelodysplasia Ulster Med J 65 1996 55
48. Jayne D, Marshall P, Jones S, et al: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990.
49. D. Jenne L. Frohlich A. Hummel Cloning and functional expression of the murine homolog of proteinase 3: Implications for the design of murine models of vasculitis FEBS Lett 408 1997 187
50. J. Jennette Antineutrophil cytoplasmic autoantibody-associated diseases: A pathologist's perspective Am J Kidney Dis 18 1991 164
51. J. Jennette R. Falk Small vessel vasculitis N Engl J Med 337 1997 1512
52. J. Jennette R. Falk K. Andrassy Nomenclature of systemic vasculitis: Proposal of an international consensus conference Arthritis Rheum 37 1994 187
53. C.A. Jennings T.E. King Jr R. Tuder Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis Am J Respir Crit Care Med 155 1997 1101
54. C. Kallenberg A. Mulder J. Tervaert Antineutrophil cytoplasmic antibodies: A still growing class of autoantibodies in inflammatory disorders Am J Med 93 1992 675
55. G. Kerr T. Fleisher C. Hallahan Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis Arthritis Rheum 36 1993 365
56. T.E. King Jr A lung biopsy is necessary in the management of ANCA-positive patients with chest roentgenographic abnormalities Sarcoidosis Vasc Diffuse Lung Dis 13 1996 238
57. S.S. Lee J.W. Lawton W. Chak Distinction between antinuclear antibody and P-ANCA J Clin Pathol 44 1991 962
58. P. Lesavre X. Kyndt P. Vanhille Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis Sarcoidosis Vasc Diffuse Lung Dis 13 1996 246
59. R. Lock Detection of autoantigens to neutrophil cytoplamsic antigens J Clin Pathol 47 1994 4
60. C. Lockwood D. Jayne P. Marshall A prospective study of the incidence of anti-GBM and antineutrophil cytoplasm antibodies in patients with rapidly progressive nephritis Kidney Int 33 1988 329
61. B. Markey J. Warren Use of antineutrophil cytoplasmic antibody assay to distinguish between vasculitis disease activity and complicaitons of cytotoxic therapy Am J Clin Pathol 102 1994 589
62. W. Mayet E. Csernok C. Szymkowiak Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis Blood 82 1993 1211
63. W. Mayet K. Meyer zum Buschenfelde Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells Clin Exp Immunol 94 1993 440
64. W.J. Mayet A. Schwarting T. Orth Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1) Clin Exp Immunol 103 1996 259
65. P.A. Merkel R.P. Polisson Y. Chang Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease Ann Intern Med 126 1997 866
66. J. Niles Antineutrophil cytoplasmic antibodies in the classification of vasculitis Annual Review of Medicine 47 1996 303
67. J. Niles E. Bottinger G. Saurina The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition Arch Intern Med 156 1996 440
68. J. Niles R. McCluskey Letter to the editor Lancet 347 1996 116
69. J.L. Niles A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis: The contra-view Sarcoidosis Vasc Diffuse Lung Dis 13 1996 232
70. K. Nishiya H. Chikazawa S. Nishimura Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus is unrelated to clinical features Clin Rheumatol 16 1997 70
71. B. Nolle U. Specks J. Ludemann Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener Granulomatosis Ann Intern Med 111 1989 28
72. D. O'Donoghue C. Short P. Brenchley Sequential development of systemic vasculitis with antineutrophil cytoplasmic antibodies complicating antiglomerular basement membrane disease Clin Nephrol 32 1989 251
73. T. Orth G. Gerken R. Kellner Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1 J Hepatol 26 1997 37
74. T. Orth G. Gerken Z.B.K.H. Meyer Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: Their prevalence and antigen specificity Z Gastroenterol 35 1997 113
75. W. Pollock K. Dunster J. Rolland A comparison of detection methods and ELISA kits for antineutrophil cytoplasm antibodies Sarcoidosis Vasc Diffuse Lung Dis 13 1996 265
76. D. Pudifin J. Duursma V. Gathiram Invasive amebiasis is associated with the development of antineutrophil cytoplasmic antibody Clin Exp Immunol 97 1994 48
77. C. Pusey C. Lockwood Autoimmunity in rapidly progressive glomerulonephritis Kidney Int 35 1989 929
78. D. Ralston C. Marsh M. Lowe Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release J Clin Invest 100 1997 1416
79. J. Rao N. Allen J. Feussner A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clincal criteria in diagnosing Wegener's granulomatosis Lancet 346 1995 926
80. J. Rao M. Weinberger E. Oddone The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis Ann Intern Med 123 1995 925
81. E. Reinhold-Keller Z. Zeidler A. Feller Active generalized Wegener's granulomatosis without ANCA-a new subset in WG? Sarcoidosis Vasc Diffuse Lung Dis 13 1996 267
82. D. Reumaux P. Vossebeld D. Roos Effect of tumor necrosis factor-induced integrin activation on Fcgamma receptor II-mediated signal transduction: Relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies Blood 86 1995 3189
83. J. Savige L. Chang S. Horn Antinuclear, antineutrophil cytoplasmic and antiglomerular basement membrane antibodies in HIV-infected individuals Autoimmunity 18 1994 205
84. J.A. Savige L. Chang L. Cook Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis Clin Exp Immunol 100 1995 194
85. A. Schnabel S. Hauschild W.L. Gross Antineutrophil cytoplasmic antibodies in generalized autoimmune diseases Int Arch Allergy Immunol 109 1996 201
86. D. Schultz E. Tozman Antineutrophil cytoplasmic antibodies: Major autoantigens, pathophysiology and disease associations Semin Arthritis Rheum 25 1995 143
87. A. Short V. Esnalult C. Lockwood Antineutrophil cytoplasmic antibodies and antiglomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis Am J Kidney Dis 26 1995 439
88. A. Short C. Lockwood A. Bollen Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis Clin Exp Immunol 102 1995 106
89. U. Sibelius K. Hattar A. Schenker Wegener's granulomatosis: Anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response J Exp Med 187 1998 497
90. U. Specks D. Fass M. Fautsch Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymically active and recognized by c-ANCA FEBS Lett 390 1996 265
91. U. Specks H. Homberger Antineutrophil cytoplasmic antibodies Mayo Clin Proc 69 1994 1197
92. U. Specks E.M. Wiegert H.A. Homburger Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for antineutrophil cytoplasmic antibodies (ANCA) Clin Exp Immunol 109 1997 286
93. G.P. Spickett V. Broomhead Formalin fixation and patterns of antineutrophil cytoplasmic antibodies J Clin Pathol 48 1995 89
94. P.E. Spronk H. Bootsma G. Horst Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus Br J Rheumatol 35 1996 625
95. C. Stegeman J. Cohen Tervaert W. Sluiter Association of chronic nasal carriage of Staphlyococcus aureus and higher relapse rates in Wegener Granulomatosis Ann Intern Med 120 1994 12
96. J.C. ter Maaten C.F. Franssen R.O. Gans Respiratory failure in ANCA-associated vasculitis Chest 110 1996 357
97. W. Travis T. Colby C. Lombard A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation Am J Surg Pathol 14 1990 1112
98. W. Travis G. Hoffman R. Leavitt Surgical pathology of the lung in Wegener's granulomatosis Am J Surg Pathol 15 1991 315
99. M. Ulmer A. Rautman W. Gross Immunodiagnostic aspects of autoantibodies against myeloperoxidase Clin Nephrol 37 1992 161
100. F. van der Woude N. Rasmussen S. Lobatto Autoantibodies against neutrophils and monocytes: Tools for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 1985 425
101. J. Velosa H. Homburger K. Holley Prospective study of antineutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitis Mayo Clin Proc 68 1993 561
102. M. Venning A. Quinn V. Broomhead Antibodies directed against neutrophils (c-ANCA and p-ANCA) are of distinct diagnostic value in systemic vasculitis Q J Med 284 1990 1287
103. G. Wang E. Csernok K. de Groot Comparison of eight commercial kits for quantification of antineutrophil cytoplasmic antibodies (ANCA) J Immunol Methods 208 1997 203
104. P. Yang Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence J Clin Pathol 50 1997 677
105. D. Zauli S. Ghetti A. Grassi Antineutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis Hepatology 25 1997 1105
106. M. Zhao D. Jayne L. Ardiles Autoantibodies against bacterial/permeability-increasing protein in patients with cystic fibrosis QJM 89 1996 259